GHDX

Genomic Health, Inc.
GHDX

Overview Fund Activity
Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

134 hedge funds and large institutions have $1B invested in Genomic Health, Inc. in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 37 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-1
Holders Change %
-0.74%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
25
Increased
47
Reduced
37
Closed
22
Calls
$4.14M
Puts
–
Net Calls
+$4.14M
Net Calls Change
+$1.12M

Top Buyers

1
Ameriprise
1
Ameriprise
Minnesota
$47.3M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$12.2M
3
State Street
3
State Street
Massachusetts
$26.2M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$37M
5
OAM
5
Oxford Asset Management
United Kingdom
$3.08M

Top Sellers

1
TCM
1
Tributary Capital Management
Nebraska
$0
2
MFWM
2
Motley Fool Wealth Management
Virginia
$0
3
MFAM
3
Motley Fool Asset Management
Virginia
$0
4
First Manhattan
4
First Manhattan
New York
$0
5
CPA
5
Cowen Prime Advisors
New York
$75K
Name Holding Trade Value Shares
Change 		Shares
Change %
FHA
151
First Horizon Advisors
Tennessee
– -$31K -890 Closed
TRCT
152
Tower Research Capital (TRC)
New York
– -$21K -615 Closed
Pacer Advisors
153
Pacer Advisors
Pennsylvania
– -$9K -250 Closed
KJWM
154
Kiley Juergens Wealth Management
Washington
– -$3K -100 Closed
GI
155
Gradient Investments
Minnesota
– -$1K -17 Closed
3 4 5 6
7